Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin-exercise interaction on glycemic control in prediabetes and recent-onset diabetes
PACTR202401506460143Phase 2Recruiting
- Sponsor
- Hôpital Universitaire Sahloul
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin and Placebo-COD Research Private Ltd in prediabetes and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Hôpital Universitaire Sahloul. Started May 2023; status: recruiting.
02
Drugs
metforminPlacebo-COD Research Private Ltd
03
Conditions
prediabetestype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on PACTR202401506460143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202401506460143.